| Trial ID: | L3959 |
| Source ID: | NCT02189395
|
| Associated Drug: |
Nph And Regular Insulin
|
| Title: |
Comparison of Neutral Protamine Hagedorn (NPH) and Lantus Based Insulin Regimen in the Management of Hypoglycemia in the Hospitalized Patients in Noncritical Care Setting
|
| Acronym: |
|
| Status: |
TERMINATED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes Mellitus
|
| Interventions: |
DRUG: NPH and regular insulin|DRUG: glargine and humalog
|
| Outcome Measures: |
Primary: difference in glycemic control between treatment groups as measured by the mean daily blood glucose, Primary outcome of the study is to determine differences in glycemic control between treatment group as measured by the mean daily blood glucose, Duration of hospital stay, up to 24 weeks | Secondary: number of hypoglycemic events, number of hypoglycemic events, duration of hospital stay, up to 24 weeks
|
| Sponsor/Collaborators: |
Sponsor: Riverside University Health System Medical Center
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
52
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2013-04
|
| Completion Date: |
2017-04
|
| Results First Posted: |
|
| Last Update Posted: |
2017-09-28
|
| Locations: |
Riverside County Regional Medical Center, Moreno Valley, California, 92555, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT02189395
|
